Polymed

Polymed has signed definitive agreements to acquire a 90% stake in PendraCare Group (PendraCare Holdings and Wellinq Medical) for an enterprise value of ₹188.5 crore (€18.3 million), gaining access to cardiology catheter solutions and regulated markets in Europe and the US.

Polymed announced plans to make three new manufacturing facilities operational over the next 12-24 months as part of scaling its manufacturing footprint to meet global demand.